StreetInsider.com News Articles

Form POS AM ADAPTIN BIO, INC.

Tue, 21 Jul 2026 17:08:00 -0400

si-local-file:///var/storage/secattach/20260721/26796453.html

Form D/A ADAPTIN BIO, INC.

Mon, 22 Jun 2026 16:41:00 -0400

si-local-file:///var/storage/secattach/20260622/26673689.html

Form 424B3 ADAPTIN BIO, INC.

Fri, 12 Jun 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260612/26641859.html

Form 10-K/A ADAPTIN BIO, INC. For: Dec 31

Fri, 12 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260612/26640680.html

Form 424B3 ADAPTIN BIO, INC.

Mon, 18 May 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260518/26514360.html

Form 10-Q ADAPTIN BIO, INC. For: Mar 31

Fri, 15 May 2026 09:01:00 -0400

si-local-file:///var/storage/secattach/20260515/26500480.html

Adaptin Bio Shares (Ticker: APTN) Commence Trading on the OTCQB

Thu, 14 May 2026 13:05:00 -0400

CHARLOTTE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Adaptin Bio, Inc. (OTCQB: APTN), (“Adaptin” or the “Company”), a biotechnology company developing precision cancer therapeutics enabled by targeted delivery to the brain and other difficult-to-reach tissues, today announced that its common stock has commenced trading on the OTCQB® Venture Market under the ticker symbol APTN. OTCQB trading is expected to provide greater access to U.S. investors, improve liquidity, and enhance visibility within the investment community.